Ricky Stuart Mofsen DO

Psychiatry•Saint Louis, MO

Psychiatrist (Therapist)

Join to View Full Profile

3535 S Jefferson AveSuite 104Saint Louis, MO 63118
Phone+1 314-776-7999
Fax+1 314-772-2257

Summary

Ricky Mofsen, DO, is a psychiatrist based Massachusetts General Hospital, who completed his medical education at Des Moines University College of Osteopathic Medicine in 1985 and a psychiatry residency at Stony Brook Medicine/University Hospital from 1986 to 1989. He is currently employed at Massachusetts General Hospital and the Translational Research Center also at MGH. Dr. Mofsen has performed over one hundred clinical trials and contributed to various publications covering topics such as the treatment of hepatitis C, psychosis, diabetes mellitus, and depression. He has been involved in multiple clinical trials focusing on treatments for opioid use disorder, schizophrenia, and major depressive disorder.

Education & Training

Stony Brook Medicine/University HospitalResidency, Psychiatry, 1986 - 1989
Des Moines University College of Osteopathic MedicineClass of 1985

Certifications & Licensure

MA State License 1994 - 2027
MO State License 1989 - 2026
NY State License 1986 - 2020
AR State License 2016 - 2018
FL State License 1989 - 2018
AOA Board of Neurology and Psychiatry Addiction Medicine (CAQ)

Clinical Trials

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease Start of enrollment: 2009 Nov 01
Completed
Phase 1
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Start of enrollment: 2013 Nov 01
Completed
Phase 3
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01
Completed
Phase 3
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Start of enrollment: 2015 Jul 27
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

17 citations
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4
Bradley D. Vince, J. Hill, Eric Lawitz, William O'Riordan, Lynn R. Webster
Journal of Hepatology. 2014-05-01
23 citations
Prospective electroconvulsive therapy in a delusional depressed patient with a frontal meningioma. A case report.
L B Greenberg, R Mofson, M Fink
The British Journal of Psychiatry. 1988-07-01

Journal Articles

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phas...
Burns DK, et. al., Lancet Neurol., 7/2021
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Sadoff, et. al., N Engl J Med, 6/10/2021
Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms.
Umbricht D et. al., Biol Psychiatry Glob Open Sci., 3/13/2021
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Haight, BR et. al., Lancet, 2/23/2019
Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous a...
Preskorn S, et. al., J Psychiatr Pract., 3/21/2015
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4.
Vince B, Hill JM, Lawitz EJ, O'Riordan W, Webster LR, Gruener DM, Mofsen RS, Murillo A, Donovan E, Chen J, McCarville JF, Sullivan-Bólyai JZ, Mayers D, Zhou XJ., J Hepatol., 5/2014
Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
Szegedi A, et. al., J Clin Psychopharmacol., 2/2012
Quetiapine in the successful treatment of psychosis and comorbid brittle diabetes mellitus: a case report.
Balter, J, Mofsen, R, Pinninti N, Int J Psychiatry Med., 2004
Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation.
Mofsen R, Balter, J, Clin Ther., 10/23/2001
Treatment of depression in the elderly.
Mofsen R, AmFamily Physician, 2/1/2001
Prospective electroconvulsive therapy in a delusional depressed patient with a frontal meningioma. A case report
LB Greenburg, R Mofsen, M FInk, Br J Psychiatry, 7/1988
Join now to see all

Committees

Ethics Committee, Schizophrenia International Research Society 2018 - Present

Professional Memberships

American Osteopathic Association - AOA
Member

Ricky Stuart Mofsen DO

Dr. Mofsen is on Doximity

Summary

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Committees

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.